Company profile
Pharmagreen Biotech Inc.
OTC: PHBI · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Coquitlam, BCCIK 0001435181Reports USD
#1 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 31
v0.1 · 5/100 weight · pillars only
↑ Piotroski F, listing tenure · ↓ balance-sheet leverage, return on assets
Methodology →Revenue TTM
$4.3M
Rev growth YoY (TTM)
+167846.3%
Net income (FY)
-$875.5k
Employees
—
as of 2026-08-26
Market cap
$115.5k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$875.5k-$875.5k2022
Operating income-$1.1M-$1.1M2022
Total assets$209.0k$209.0k2022
Liabilities$2.0M$2.0M2022
Equity-$1.8M-$1.8M2022
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Pharmagreen Biotech Inc.’s financial profile?
Pharmagreen Biotech Inc. earned -$875.5k in FY2022 net income.
Peers · Healthcare
Tian'an Pharmaceutical Co., Ltd.——StageZero Life Sciences Ltd.——Asep Medical Holdings Inc——Green Rain Energy Holdings Inc.——Hard to Treat Diseases Inc.——MedGen, Inc.——Key facts
CEOPeter Wojcik
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCoquitlam, BC
ExchangeOTC: PHBI
Employees—
IPO date2018-08-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.